KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to -$212.0 million.

  • Merck's Deferred Taxes rose 4713.22% to -$212.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year increase of 652.17%. This contributed to the annual value of -$1.2 billion for FY2024, which is 3422.85% up from last year.
  • Latest data reveals that Merck reported Deferred Taxes of -$212.0 million as of Q3 2025, which was up 4713.22% from -$448.0 million recorded in Q2 2025.
  • Merck's 5-year Deferred Taxes high stood at $159.0 million for Q4 2021, and its period low was -$931.0 million during Q4 2023.
  • Moreover, its 5-year median value for Deferred Taxes was -$277.0 million (2023), whereas its average is -$282.9 million.
  • As far as peak fluctuations go, Merck's Deferred Taxes surged by 12658.86% in 2021, and later tumbled by 6600000.0% in 2022.
  • Merck's Deferred Taxes (Quarter) stood at $159.0 million in 2021, then tumbled by 293.08% to -$307.0 million in 2022, then crashed by 203.26% to -$931.0 million in 2023, then soared by 33.83% to -$616.0 million in 2024, then skyrocketed by 65.58% to -$212.0 million in 2025.
  • Its Deferred Taxes stands at -$212.0 million for Q3 2025, versus -$448.0 million for Q2 2025 and -$186.0 million for Q1 2025.